Jane Street Group, LLC Agenus Inc Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$2.35 - $3.47 $401,380 - $592,676	-170,800 Reduced 64.43%	94,300 $232,000
Q4 2021 Feb 15, 2022	SELL	$2.92 - $5.74 $428,656 - $842,632	-146,800 Reduced 35.64%	265,100 $854,000
Q3 2021 Nov 16, 2021	SELL	$4.98 - $6.63 $505,968 - $673,608	-101,600 Reduced 19.79%	411,900 $2.16 Million
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $1.02 Million - $2.19 Million	398,100 Added 344.97%	513,500 $2.82 Million
Q1 2021 May 18, 2021	BUY	$2.69 - $5.25 $251,784 - $491,400	93,600 Added 429.36%	115,400 $314,000
Q4 2020 Feb 17, 2021	SELL	$3.17 - $4.49 $286,251 - $405,447	-90,300 Reduced 80.55%	21,800 $69,000
Q3 2020 Nov 17, 2020	BUY	$2.98 - $5.2 $334,058 - $582,920	112,100 New	112,100 $448,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.